Compare with MANGALAM DRUGS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs MANGALAM DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZIM LABORATORIES MANGALAM DRUGS ZIM LABORATORIES/
MANGALAM DRUGS
 
P/E (TTM) x 30.1 11.0 272.7% View Chart
P/BV x 1.2 1.5 79.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ZIM LABORATORIES   MANGALAM DRUGS
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-21
MANGALAM DRUGS
Mar-21
ZIM LABORATORIES/
MANGALAM DRUGS
5-Yr Chart
Click to enlarge
High Rs131175 75.0%   
Low Rs5332 165.9%   
Sales per share (Unadj.) Rs189.2221.1 85.6%  
Earnings per share (Unadj.) Rs4.517.7 25.5%  
Cash flow per share (Unadj.) Rs14.223.5 60.6%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs99.082.7 119.6%  
Shares outstanding (eoy) m16.2415.83 102.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.50.5 104.0%   
Avg P/E ratio x20.55.9 349.0%  
P/CF ratio (eoy) x6.54.4 146.8%  
Price / Book Value ratio x0.91.3 74.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,4971,639 91.3%   
No. of employees `000NANA-   
Total wages/salary Rs m358299 119.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,0733,500 87.8%  
Other income Rs m2347 49.5%   
Total revenues Rs m3,0963,547 87.3%   
Gross profit Rs m346533 64.9%  
Depreciation Rs m15892 172.1%   
Interest Rs m10993 116.9%   
Profit before tax Rs m102395 25.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m29115 25.2%   
Profit after tax Rs m73280 26.2%  
Gross profit margin %11.315.2 73.9%  
Effective tax rate %28.529.2 97.5%   
Net profit margin %2.48.0 29.8%  
BALANCE SHEET DATA
Current assets Rs m1,9181,320 145.3%   
Current liabilities Rs m1,4201,076 132.0%   
Net working cap to sales %16.27.0 232.7%  
Current ratio x1.41.2 110.1%  
Inventory Days Days167 230.9%  
Debtors Days Days858559 153.6%  
Net fixed assets Rs m1,3041,309 99.7%   
Share capital Rs m162158 102.6%   
"Free" reserves Rs m1,4451,151 125.5%   
Net worth Rs m1,6081,310 122.7%   
Long term debt Rs m21869 317.5%   
Total assets Rs m3,2222,628 122.6%  
Interest coverage x1.95.2 37.0%   
Debt to equity ratio x0.10.1 258.6%  
Sales to assets ratio x1.01.3 71.6%   
Return on assets %5.714.2 39.8%  
Return on equity %4.621.4 21.3%  
Return on capital %11.635.4 32.7%  
Exports to sales %67.40-   
Imports to sales %4.143.0 9.6%   
Exports (fob) Rs m2,072NA-   
Imports (cif) Rs m1271,506 8.5%   
Fx inflow Rs m2,1401,421 150.6%   
Fx outflow Rs m1271,507 8.5%   
Net fx Rs m2,012-85 -2,355.5%   
CASH FLOW
From Operations Rs m319276 115.6%  
From Investments Rs m-59-313 18.8%  
From Financial Activity Rs m-26027 -962.7%  
Net Cashflow Rs m-1-10 6.7%  

Share Holding

Indian Promoters % 33.3 50.5 65.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 66.7 49.5 134.9%  
Shareholders   4,610 21,071 21.9%  
Pledged promoter(s) holding % 0.0 11.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZIM LABORATORIES With:   J.B.CHEMICALS  GLAND PHARMA  BETA DRUGS   LINK PHARMA  GUJ.THEMIS.  



Today's Market

Sensex Jumps 550 Points, Nifty Above 17,000; Metal & Banking Stocks Rally(10:30 am)

Asian stock markets are higher today as investors took heart from strong rebounds on Wall Street on hopes that the newest coronavirus variant will prove less virulent than earlier strains.

Related Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ZIM LABORATORIES SHARE PRICE


Dec 7, 2021 12:22 PM

TRACK ZIM LABORATORIES

  • Track your investment in ZIM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZIM LABORATORIES

ZIM LABORATORIES 5-YR ANALYSIS

COMPARE ZIM LABORATORIES WITH

MARKET STATS